These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 27591880)

  • 41. Role of mesangial expansion in the pathogenesis of diabetic nephropathy.
    Dalla Vestra M; Saller A; Mauer M; Fioretto P
    J Nephrol; 2001; 14 Suppl 4():S51-7. PubMed ID: 11798146
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of long-term treatment with insulin and/or acarbose on glomerular basement membrane thickening in alloxan-diabetic rats.
    Macedo CS; Silva MD; Spadella CT; Breim LC; Capeletti S; Mercadante MC; Hernandes D; Macedo AR
    Braz J Med Biol Res; 1996 Oct; 29(10):1329-35. PubMed ID: 9181105
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression.
    Alhaider AA; Korashy HM; Sayed-Ahmed MM; Mobark M; Kfoury H; Mansour MA
    Chem Biol Interact; 2011 Jul; 192(3):233-42. PubMed ID: 21457706
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Renoprotective effect of atorvastatin on STZ-diabetic rats through attenuating kidney-associated dysmetabolism.
    Zhou S; Zhao P; Li Y; Deng T; Tian L; Li H
    Eur J Pharmacol; 2014 Oct; 740():9-14. PubMed ID: 25008071
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression.
    Ojima A; Ishibashi Y; Matsui T; Maeda S; Nishino Y; Takeuchi M; Fukami K; Yamagishi S
    Am J Pathol; 2013 Jan; 182(1):132-41. PubMed ID: 23159951
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria.
    Wang A; Ziyadeh FN; Lee EY; Pyagay PE; Sung SH; Sheardown SA; Laping NJ; Chen S
    Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1657-65. PubMed ID: 17804483
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dipeptidyl peptidase-4 inhibition with linagliptin and effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: Rationale and design of the MARLINA-T2D™ trial.
    Groop PH; Cooper ME; Perkovic V; Sharma K; Schernthaner G; Haneda M; Hocher B; Gordat M; Cescutti J; Woerle HJ; von Eynatten M
    Diab Vasc Dis Res; 2015 Nov; 12(6):455-62. PubMed ID: 26224765
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of ACE inhibition on the expression of type IV collagen and laminin in renal glomeruli in experimental diabetes.
    Erensoy N; Yilmazer S; Oztürk M; Tunçdemir M; Uysal O; Hatemi H
    Acta Histochem; 2004; 106(4):279-87. PubMed ID: 15350810
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Growth hormone enhances basement membrane thickening in experimental diabetes. A preliminary report.
    Osterby R; Seyer-Hansen K; Gundersen HJ; Lundbaek K
    Diabetologia; 1978 Dec; 15(6):487-9. PubMed ID: 720783
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lack of {alpha}8-integrin aggravates podocyte injury in experimental diabetic nephropathy.
    Hartner A; Cordasic N; Menendez-Castro C; Volkert G; Yabu JM; Kupraszewicz-Hutzler M; Rascher W; Hilgers KF
    Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1151-7. PubMed ID: 20826576
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute Effects of Linagliptin on Progenitor Cells, Monocyte Phenotypes, and Soluble Mediators in Type 2 Diabetes.
    Fadini GP; Bonora BM; Cappellari R; Menegazzo L; Vedovato M; Iori E; Marescotti MC; Albiero M; Avogaro A
    J Clin Endocrinol Metab; 2016 Feb; 101(2):748-56. PubMed ID: 26695864
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Morphometric detection of incipient glomerular lesions in diabetic nephropathy in rats. Protective effects of ACE inhibition.
    Sassy-Prigent C; Heudes D; Jouquey S; Auberval D; Belair MF; Michel O; Hamon G; Bariety J; Bruneval P
    Lab Invest; 1995 Jul; 73(1):64-71. PubMed ID: 7603042
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The inhibitory effect of lysozyme on the glomerular basement membrane thickening in spontaneous diabetic mice (NSY mice).
    Shibata M; Kishi T; Yasuda B; Kuno T
    Tohoku J Exp Med; 1986 May; 149(1):39-46. PubMed ID: 3738916
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of diet composition on renal morphology in diabetic rats.
    Dumler F; Schmidt R; Vera G; Cortes P; Bernstein J
    Miner Electrolyte Metab; 1992; 18(2-5):120-2. PubMed ID: 1465045
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metabolic and ultrastructural aspects of experimental diabetic glomerulopathy.
    Martino G; Botte L; Gualà L; Covello C
    J Endocrinol Invest; 1986 Apr; 9(2):87-95. PubMed ID: 3011887
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quantitative studies of glomerular ultrastructure in human and experimental diabetes.
    Osterby R; Brekke IB; Gundersen HJ; Jørgensen HE; Løkkegaard H; Mogensen CE; Nyberg G; Parving HH; Westberg G
    Appl Pathol; 1984; 2(4):205-11. PubMed ID: 6545133
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Etiologic variability of nephropathy in juvenile diabetes mellitus.
    Gilboa N; Durante D; McIntosh RM; Guggenheim S
    Arch Pathol Lab Med; 1979 Aug; 103(9):479-82. PubMed ID: 582380
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy.
    Marchant V; Droguett A; Valderrama G; Burgos ME; Carpio D; Kerr B; Ruiz-Ortega M; Egido J; Mezzano S
    Am J Physiol Renal Physiol; 2015 Sep; 309(6):F559-68. PubMed ID: 26155842
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of prolonged hyperglycemia with glomerular hypertrophy and renal basement membrane thickening in the Goto Kakizaki model of non-insulin-dependent diabetes mellitus.
    Phillips AO; Baboolal K; Riley S; Gröne H; Janssen U; Steadman R; Williams J; Floege J
    Am J Kidney Dis; 2001 Feb; 37(2):400-10. PubMed ID: 11157383
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The kidney in diabetes.
    Mauer SM; Steffes MW; Brown DM
    Am J Med; 1981 Mar; 70(3):603-12. PubMed ID: 7011015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.